Dune launches MarginProbe trial

By AuntMinnie.com staff writers

October 29, 2008 -- Israeli firm Dune Medical Devices has begun a U.S. clinical trial of its MarginProbe intraoperative breast cancer probe.

The U.S. Food and Drug Administration (FDA) recently granted the Caesarea-based company an investigational device exemption for its breast cancer surgery protocol. MarginProbe uses radiofrequency spectroscopy to characterize breast tissue during surgery to determine the malignancy status of tumor margins.

The study will involve more than 600 women in more than a dozen medical centers in New York City; Baltimore; Washington, DC; Allentown, PA; and Los Angeles, Dune said.

Dune Medical device shows promise for re-excision surgeries, May 11, 2007

Copyright © 2008 AuntMinnie.com


To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking